FrancophonIA/ELRC3.0 huggingface dataset:
English: Nevertheless, renal oxygen consumption, and hence renal function, are preserved at mean arterial pressures above 60 mmHg in dogs and cats.
Croatian: Ipak, potrošnja kisika u bubregu, a time i funkcija bubrega, očuvani su pri prosječnom arterijskom tlaku većem od 60 mmHg i mačaka.
English: 100% v/v sevoflurane.
Croatian: 100% v/v sevofluran.
English: ESPAÑA Tel: +34 93 4802277
Croatian: Barcelona . ESPAÑA Tel: +34 93 4802277
English: In order to minimise this reaction in rebreathing anaesthetic circuits, Sevohale should not be passed through soda lime or barium hydroxide that has been allowed to dry out.
Croatian: Da bi se smanjila ova reakcija u ciklusu ponovnog udisanja anestetika, Sevohale se ne smije propuštati kroz smjesu kalcijevog, natrijevog i kalijevog hidroksida ili barijev hidroksida koji su se osušili.
English: • Use a cuffed endotracheal tube when possible for the administration of Sevohale during maintenance anaesthesia.
Croatian: • Kad je to moguće, koristite endotrahealni tubus s balončićem za primjenu Sevohalea tijekom održavanja anestezije.
English: Sevoflurane may trigger episodes of malignant hyperthermia in susceptible dogs and cats.
Croatian: Sevofluran može izazvati epizode maligne hipertermije u osjetljivih pasa i mačaka.
English: Sevohale 100% v/v Inhalation vapour, liquid for dogs and cats.
Croatian: Sevohale 100% v/v para inhalata, tekućina za pse i mačke.
English: Limited data are available on the effects of the highly potent alpha-2agonists (medetomidine, romifidine and dexmedetomidine) as premedication.
Croatian: Dostupni su ograničeni podaci o učincima visoko potentnih alfa-2-agonista (medetomidina, romifidina i deksmedetomidina) u premedikaciji, koji se stoga moraju koristiti s oprezom.
English: Doses required for maintenance of anaesthesia may need to be reduced by approximately 0.5% in geriatric dogs (i.e. 2.8% to 3.1% in premedicated geriatric dogs and 3.2 to 3.3% in unpremedicated geriatric dogs).
Croatian: Doze potrebne za održavanje anestezije u starih pasa možda će trebati smanjiti za približno 0,5% (tj. za 2,8% do 3,1% nakon premedikacije u starih pasa te za 3,2% do 3,3% u starih pasa bez premedikacije).
English: • Care should be taken when dispensing Sevohale, with immediate removal of any spillage.
Croatian: • Sevohale treba pažljivo primjenjivati, a ukoliko se prolije, odmah očistiti.
English: Sevoflurane is an inhalational anaesthetic agent, having a light odour, for induction and maintenance of general anaesthesia.
Croatian: Sevofluran je inhalacijski anestetik blagog mirisa za uvođenje u anesteziju i održavanje opče anestezije.
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Croatian: Posebne mjere opreza koje mora poduzeti osoba koja primjenjuje veterinarsko- medicinski proizvod na životinjama
English: Inhalation vapour, liquid.
Croatian: Para inhalata, tekućina.
English: Sevoflurane 100% v/v
Croatian: Sevofluran 100% v/v
English: In dogs, the concurrent administration of thiopental, however, may slightly increase sensitivity to adrenaline induced cardiac arrhythmias.
Croatian: U pasa, istodobna primjena tiopentala, međutim, može blago povećati osjetljivost na srčane aritmije izazvane adrenalinom.
English: Inhalation vapour, liquid
Croatian: Para inhalata, tekućina
English: Reaction with barium hydroxide results in a greater production of Compound A than does the reaction with soda lime.
Croatian: Reakcija s barijevim hidroksidom rezultira većom proizvodnjom Spoja A nego reakcija s mješavinom kalcijevog, natrijevog i kalijevog hidroksida.
English: 100% v/v sevoflurane
Croatian: 100% v/v sevofluran
English: However, there is limited clinical experience of the use of sevoflurane, after propofol induction, in bitches and queens undergoing caesarean section, without any ill effects being detected in either the bitch or queen, or the puppies or kittens.
Croatian: Međutim, postoji ograničeno kliničko iskustvo uporabe sevoflurana nakon uvođenja u anesteziju propofolom kod kuja u kojih će se raditi carski rez, bez ikakvih primjetnih štetnih učinaka na kuji ili štencima.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton box
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU
English: which are typically 1.3 to 1.5 times the MAC value.
Croatian: Višekratnici MAC-a služe kao vodič kod kirurške razine anestezije, koje su obično 1,3 do 1,5 puta veći od vrijednosti MAC.
English: C.
Croatian: D.
English: Sevoflurane degradation in soda lime has been shown to increase with temperature.
Croatian: Pokazalo se da se raspad sevoflurana u mješavini kalcijevog, natrijevog i kalijevog hidroksida povećava s temperaturom.
English: • Avoid using masking procedures for prolonged induction and maintenance of general anaesthesia.
Croatian: • Za dugotrajnije uvođenje u anesteziju i održavanje opće anestezije izbjegavajte koristiti postupke s maskom.
English: The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Croatian: Nemojte koristiti ovaj veterinarsko-medicinski proizvod tijekom graviditeta i laktacije, jer nije utvrđena neškodljivost njegove primjene tijekom graviditeta i laktacije.
English: However, there is limited clinical experience of the use of sevoflurane, after propofol induction, in bitches and queens undergoing caesarean section, without any ill effects being detected in either the bitch or queen or the puppies or kittens.
Croatian: Međutim, kod kuja i mačaka u kojih će se raditi carski rez, postoji ograničeno kliničko iskustvo uporabe sevoflurana nakon uvođenja u anesteziju propofolom , bez ikakvih primjetnih štetnih učinaka na kuji ili mački te štencima ili mačićima.
English: Sevoflurane administration adversely affects the autoregulation of renal blood flow in dogs and cats.
Croatian: Primjena sevoflurana šetno utječe na autoregulaciju protoka krvi kroz bubreg u pasa.
English: Further information on Ervebo can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/Ervebo.
Croatian: Više informacija o lijeku Ervebo dostupno je na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/Ervebo.
English: People received a single dose of Ervebo either immediately or after 21 days.
Croatian: Te su osobe primile jednu dozu cjepiva Ervebo odmah ili nakon 21 dana.
English: Ervebo is given by a trained healthcare worker.
Croatian: Ervebo daje obučen zdravstveni radnik.
English: Amongst the 2,108 people who received immediate vaccination, none had Ebola virus disease between 10 days and 31 days after vaccination; amongst those whose vaccination was delayed (1429 people), 10 developed the disease within 31 days after vaccination.
Croatian: Među 2108 osoba koje su cijepljene odmah, nijedna nije imala ebolu između 10. i 31. dana nakon cijepljenja; među onima u kojih je cijepljenje bilo odgođeno (1429 osoba), 10 ih je razvilo bolest unutar 31 dana nakon cijepljenja.
English: It is given as a single 1 ml injection into the muscle around the shoulder (the deltoid) or a muscle of the thigh.
Croatian: Daje se kao jedna injekcija od 1 ml u mišić oko ramena (deltoidni mišić) ili u mišić bedra.
English: This means that there is more evidence to come about the vaccine, which the company is required to provide.
Croatian: To znači da se očekuju dodatni podatci o lijeku koje tvrtka mora dostaviti.
English: The vesicular stomatitis virus itself has little or no effect on humans.
Croatian: Virus vezikularnog stomatitisa, sam za sebe, ima mali ili nikakav učinak na ljude.
English: Ervebo can only be obtained with a prescription and should be used in accordance with official recommendations.
Croatian: Ervebo se izdaje samo na recept i treba se primjenjivati u skladu sa službenim preporukama.
English: What is Ervebo and what is it used for?
Croatian: Što je Ervebo i za što se koristi?
English: What measures are being taken to ensure the safe and effective use of Ervebo?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Ervebo?
English: The most common side effects with Ervebo (which may affect more than 1 in 10 people) are pain, swelling and redness at the injection site, headache, fever, muscle pain, tiredness and joint pain.
Croatian: Najčešće nuspojave lijeka Ervebo (mogu se javiti u više od 1 na 10 osoba) jesu bol, oticanje i crvenilo na mjestu primjene injekcije, glavobolja, vrućica, bol u mišićima, umor i bol u zglobovima.
English: Ervebo must not be used in people who are hypersensitive (allergic) to rice or to any ingredients of the vaccines.
Croatian: Ervebo se ne smije primjenjivati u osoba koje su preosjetljive (alergične) na rižu ili bilo koji drugi sastojak cjepiva.
English: The effectiveness of the vaccine to protect against confirmed Ebola virus disease was measured by comparing the number of cases occurring 10 to 31 days after vaccination in the group of people vaccinated immediately, versus the number of cases in the group of people who were vaccinated later.
Croatian: Učinkovitost cjepiva za zaštitu protiv potvrđene ebole mjerena je usporedbom broja slučajeva koji su se pojavili od 10. do 31. dana nakon cijepljenja u skupini osoba koje su bile cijepljene odmah, naspram broja slučajeva u skupini osoba koje su bile cijepljene kasnije.
English: When a person receives the vaccine, it triggers an immune response against the virus protein.
Croatian: Kada osoba primi cjepivo, ono potakne imunosni odgovor protiv proteina virusa.
English: Ervebo has been given ‘conditional authorisation'.
Croatian: Za lijek Ervebo izdano je „uvjetno odobrenje”.
English: Since Ervebo has been given conditional authorisation, the company that markets Ervebo will provide additional details on certain aspects of the production process.
Croatian: Budući da je lijek Ervebo dobio uvjetno odobrenje, tvrtka koja stavlja Ervebo u promet mora dostaviti dodatne podatke o nekim aspektima proizvodnog procesa.
English: Other information about Ervebo
Croatian: Ostale informacije o lijeku Ervebo
English: The European Medicines Agency therefore decided that Ervebo's benefits are greater than its risks and that it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove stoga je zaključila da koristi od lijeka Ervebo nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u EU-u.
English: In general, these reactions occur within 7 days after vaccination, were mild to moderate in intensity and resolved in less than a week.
Croatian: Te se reakcije obično pojave unutar sedam dana nakon cijepljenja, blage su do umjerene težine i povuku se u manje od tjedan dana.
English: The vaccine only contains one protein from Zaire Ebola virus and cannot cause the disease.
Croatian: Cjepivo sadrži samo jedan protein Zair Ebolavirusa i ne može prouzročiti bolest.
English: Later, when the person comes into contact with the actual virus, the immune system recognises the virus protein and is already prepared to attack the virus and so protects the person from Ebola virus disease.
Croatian: Kasnije, kada osoba dođe u doticaj sa stvarnim virusom, imunosni sustav prepozna protein virusa i već je pripremljen da napadne virus i time zaštiti osobu od ebole.
English: What are the risks associated with Ervebo?
Croatian: Koji su rizici povezani s lijekom Ervebo?
English: Ervebo is effective in protecting adults from Ebola virus disease; however, the duration of this protection is currently unknown.
Croatian: Cjepivo Ervebo učinkovito je za zaštitu odraslih protiv virusne bolesti ebole; međutim, trajanje te zaštite trenutačno nije poznato.
English: For more information about using Ervebo, see the package leaflet or contact your doctor or pharmacist.
Croatian: Za više informacija o primjeni lijeka Ervebo pročitajte uputu o lijeku odnosno obratite se liječniku ili ljekarniku.
English: As for all medicines, data on the use of Ervebo are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Ervebo kontinuirano se prate.
English: An overview of Ervebo and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Ervebo i zašto je odobren u EU-u
English: Side effects with Ervebo were similar to those of most vaccines; they were mild to moderate in intensity and generally lasted less than a week.
Croatian: Nuspojave cjepiva Ervebo bile su slične onima u većine cjepiva; bile su blage do umjerene težine i uglavnom su trajale manje od tjedan dana.
English: Healthcare workers and other carers who have been vaccinated with Ervebo should also continue to apply standard precautions for safe injection and hygiene and wear personal protective equipment when caring for patients with known or suspected Ebola virus disease.
Croatian: Zdravstveni radnici i drugi njegovatelji koji su cijepljeni cjepivom Ervebo moraju i dalje primjenjivati standardne mjere opreza koje se odnose na sigurno injiciranje i higijenu te nositi osobnu zaštitnu opremu kada njeguju bolesnike za koje se zna ili se sumnja da imaju ebolu.
English: Why is Ervebo authorised in the EU?
Croatian: Zašto je lijek Ervebo odobren u EU-u?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ervebo have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Ervebo nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: Ervebo contains a virus known as vesicular stomatitis virus which has been weakened and modified to contain a protein from the Zaire Ebola virus.
Croatian: Ervebo sadrži virus poznat kao virus vezikularnog stomatitisa koji je oslabljen i modificiran tako da sadrži protein Zair Ebolavirusa.
English: The study was conducted in Guinea during an Ebola outbreak and involved people who were either direct contacts or contacts of contacts of someone who had Ebola virus disease.
Croatian: Ispitivanje je provedeno u Gvineji tijekom epidemije ebole i uključilo je osobe koje su bile u izravnom kontaktu s oboljelom osobom ili su bile u dodiru s drugim osobama koje su bile u kontaktu s nekim tko je imao ebolu.
English: A main study showed that Ervebo was effective in preventing Ebola virus disease in adults at risk of infection during an outbreak.
Croatian: Glavno je ispitivanje pokazalo da je Ervebo učinkovit u sprječavanju ebole u odraslih u kojih postoji rizik od infekcije tijekom epidemije.
English: Side effects reported with Ervebo are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Ervebo pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: What information is still awaited for Ervebo?
Croatian: Koje se još informacije očekuju o lijeku Ervebo?
English: Ervebo is a vaccine to protect adults aged 18 years and older against Ebola virus disease caused by the Zaire Ebola virus.
Croatian: Ervebo je cjepivo za zaštitu odraslih u dobi od 18 i više godina od virusne bolesti ebole prouzročene Zair Ebolavirusom.
English: How does Ervebo work?
Croatian: Kako djeluje Ervebo?
English: Ervebo should be used in individuals at risk of infection with Ebola virus.
Croatian: Ervebo treba davati osobama u kojih postoji rizik od infekcije virusom ebole.
English: People vaccinated with Ervebo should continue to take precautions to protect themselves from Ebola virus disease.
Croatian: Osobe cijepljene cjepivom Ervebo moraju nastaviti s mjerama opreza kako bi se zaštitile od virusne bolesti ebole.
English: What benefits of Ervebo have been shown in studies?
Croatian: Koje su koristi od lijeka Ervebo utvrđene u ispitivanjima?
English: For the full list of side effects and restrictions of Ervebo, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja povezanih s primjenom lijeka Ervebo potražite u uputi o lijeku.
English: The active substance in Ervebo contains a protein found on the Ebola Zaire virus.
Croatian: Djelatna tvar u cjepivu Ervebo sadrži protein koji se nalazi i u Zair Ebolavirusu.
English: How is Ervebo used?
Croatian: Kako se Ervebo primjenjuje?
English: Annex related to the Art. 127a
Croatian: Dodatak vezan za članak 127a
English: Conditions or restrictions with regard to the safe and effective use of the medicinal product to be implemented by the Member States
Croatian: Uvjeti ili ograničenja vezani uz sigurnu i učinkovitu primjenu lijeka koji se imaju provesti u zemljama članicama
English: The full EPAR for Entecavir Mylan can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Entecavir Mylan nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The 0.5 mg dose can be taken with or without food, but the 1 mg dose must be taken at least 2 hours before or 2 hours after a meal.
Croatian: Doza od 0,5 mg može se uzimati s hranom ili bez nje, ali doza od 1 mg mora se uzeti najmanje dva sata prije ili dva sata nakon obroka.
English: Entecavir Mylan is taken once a day.
Croatian: Entecavir Mylan uzima se jednom dnevno.
English: This means that Entecavir Mylan contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the European Union (EU) called Baraclude.
Croatian: To znači da Entecavir Mylan sadržava istu djelatnu tvar i djeluje na isti način kao i „referentni lijek” koji je već odobren u Europskoj uniji (EU) pod nazivom Baraclude.
English: Entecavir Mylan can only be obtained with a prescription and is available as tablets (0.5 mg and 1 mg).
Croatian: Entecavir Mylan izdaje se samo na liječnički recept i dostupan je u obliku tableta (od 0,5 mg i 1 mg).
English: Entecavir Mylan is a medicine used to treat chronic (long-term) hepatitis B (an infectious disease of the liver, caused by the hepatitis B virus).
Croatian: Entecavir Mylan je lijek koji se koristi za liječenje kroničnog (dugotrajnog) hepatitisa B (infektivne bolesti jetre koju uzrokuje virus hepatitisa B).
English: Patients who have not been treated before with a nucleoside analogue receive a 0.5 mg dose, while those who have received lamivudine before but whose infection is no longer responding to it are given a 1 mg dose.
Croatian: Bolesnici koji nisu prethodno liječeni analogom nukleozida primaju dozu od 0,5 mg, a oni prethodno liječeni lamivudinom u kojih infekcija više ne reagira na ovaj lijek primaju dozu od 1 mg.
English: Because Entecavir Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je lijek Entecavir Mylan generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: This is a summary of the European public assessment report (EPAR) for Entecavir Mylan.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) za lijek Entecavir Mylan.
English: Treatment with Entecavir Mylan should be started by a doctor with experience in the management of chronic hepatitis B.
Croatian: Liječenje lijekom Entecavir Mylan mora započeti liječnik s iskustvom u liječenju kroničnog hepatitisa B.
English: As for every medicine, the company provided studies on the quality of Entecavir Mylan.
Croatian: Kao i za svaki lijek, tvrtka je dostavila ispitivanja o kvaliteti lijeka Entecavir Mylan.
English: For adults with compensated liver disease, the dose depends on whether or not the patient has been previously treated with a medicine in the same group as Entecavir Mylan (a nucleoside analogue, such as lamivudine).
Croatian: Doza u odraslih bolesnika s kompenziranom bolešću jetre ovisi o tome je li bolesnik prethodno liječen lijekom iz iste skupine kao Entecavir Mylan (analogom nukleozida, poput lamivudina).
English: The European Medicines Agency concluded that, in accordance with EU requirements, Entecavir Mylan has been shown to have comparable quality and to be bioequivalent to Baraclude.
Croatian: Europska agencija za lijekove zaključila je kako je, u skladu sa zahtjevima EU-a, lijek Entecavir Mylan dokazao usporedivu kakvoću te da je bioekvivalentan lijeku Baraclude.
English: What is Entecavir Mylan and what is it used for?
Croatian: Što je Entecavir Mylan i za što se koristi?
English: Studies on the benefits and risks of the active substance in the approved uses have already been carried out with the reference medicine, Baraclude, and do not need to be repeated for Entecavir Mylan.
Croatian: Ispitivanja o koristima i rizicima djelatne tvari pri odobrenoj primjeni već su provedena za referentni lijek Baraclude te ih ne treba ponavljati za lijek Entecavir Mylan.
English: What measures are being taken to ensure the safe and effective use of Entecavir Mylan?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Entecavir Mylan?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Entecavir Mylan have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Entecavir Mylan nalaze se u sažetku opisa svojstava i u uputi o lijeku.
English: Children weighing 32.6 kg and above can be given the 0.5 mg tablets, while an oral solution of entecavir should be used for children weighing less than 32.6 kg. For further information, see the package leaflet.
Croatian: Djeci tjelesne težine 32,6 kg i veće mogu se davati tablete od 0,5 mg, a u djece tjelesne težine manje od 32,6 kg treba primjenjivati oralnu otopinu entekavira.
English: Entecavir Mylan entecavir
Croatian: Entecavir Mylan entekavir
English: The Agency recommended that Entecavir Mylan be approved for use in the EU.
Croatian: Agencija je preporučila davanje odobrenja za stavljanje lijeka Entecavir Mylan u promet u EU-u.
English: Entecavir interferes with the action of a viral enzyme, DNA polymerase, which is involved in the formation of viral DNA.
Croatian: Entekavir sprječava djelovanje virusnog enzima, DNK polimeraze, koji sudjeluje u stvaranju virusnog DNK.
English: The active substance in Entecavir Mylan, entecavir, is an antiviral belonging to the class of the nucleoside analogues.
Croatian: Djelatna tvar lijeka Entecavir Mylan, entekavir, jest antivirotik koji pripada razredu analoga nukleozida.
English: For more information about treatment with Entecavir Mylan, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o primjeni lijeka Entecavir Mylan pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svojem liječniku ili ljekarniku.
English: Therefore, the Agency's view was that, as for Baraclude, the benefit outweighs the identified risk.
Croatian: Stoga je stav Agencije da korist nadmašuje identificirani rizik, kao i za lijek Baraclude.
English: For practical information about using Entecavir Mylan, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Entecavir Mylan bolesnici trebaju pročitati u uputi o lijeku, odnosno obratiti se svom liječniku ili ljekarniku.
English: It is not intended to provide practical advice on how to use Entecavir Mylan.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Entecavir Mylan.
English: Entecavir Mylan contains the active substance entecavir and is a ‘generic medicine'.
Croatian: Entecavir Mylan sadržava djelatnu tvar entekavir te je „generički lijek”.
English: Other information about Entecavir Mylan
Croatian: Ostale informacije o lijeku Entecavir Mylan
English: What are the benefits and risks of Entecavir Mylan?
Croatian: Koje su koristi i rizici od lijeka Entecavir Mylan?
English: Why is Entecavir Mylan approved?
Croatian: Zašto je lijek Entecavir Mylan odobren?
English: How is Entecavir Mylan used?
Croatian: Kako se Entecavir Mylan koristi?
English: How has Entecavir Mylan been studied?
Croatian: Kako je Entecavir Mylan ispitivan?